As new methods of induced pluripotent stem cell generation are developed, Stemgent works to identify, validate and deliver new reprogramming technologies. Our current product portfolio includes small molecules, proteins, viral delivery systems, and cytokines.
Stemgent's products for self-renewal and expansion of cells provide greater control over culture conditions and the consistency required for reproducible results. Our products include media, matrices, growth factors and cytokines, small molecules and antibodies.
Products designed to provide tools needed for the differentiation of pluripotent stem cells. Our product offering includes the latest advancements in culture environments, small molecules and antibodies for characterization and selection.